General Information of Drug (ID: DMN2809)

Drug Name
MT201
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0AG6K

References

1 ClinicalTrials.gov (NCT00866944) Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases. U.S. National Institutes of Health.